Risk-Based Monitoring in Clinical Trials
Federico Melo Ferrer · 2014
T homas Edison was once asked the reason for his success. He replied that it was because he failed earlier than others, which enabled him to pursue new projects, ideas, or variations of his previous research endeavors. The pharmaceutical industry has been displaying stagnation in its research and